4DRU
HCV NS5B in complex with macrocyclic INDOLE INHIBITOR
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X06DA |
Synchrotron site | SLS |
Beamline | X06DA |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009 |
Detector | MAR CCD 165 mm |
Wavelength(s) | 0.97800 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 105.130, 106.643, 133.286 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.630 - 2.100 |
R-factor | 0.18536 |
Rwork | 0.185 |
R-free | 0.22557 |
Structure solution method | OTHER |
RMSD bond length | 0.011 |
RMSD bond angle | 1.304 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Refinement software | REFMAC (5.2.0005) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 83.330 | 2.230 |
High resolution limit [Å] | 2.100 | 2.100 |
Rmerge | 0.098 | 0.672 |
Number of reflections | 87966 | |
Completeness [%] | 98.8 | 98.5 |
Redundancy | 4.2 | 4.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.25 | 19% PEG 6000, 300mM ammonium sulphate buffer. The NS5b-inhibitor complex was formed by co-crystallization, with the protein solution incubated with ligand for 1 hour prior to preparation of the crystallization drops, pH 5.25, VAPOR DIFFUSION, HANGING DROP |